Literature DB >> 15518609

Gender and risk of adverse outcomes in heart failure.

Wendy Y Lee1, Angela M Capra, Nancy G Jensvold, Jerry H Gurwitz, Alan S Go.   

Abstract

Congestive heart failure (CHF) is the leading cause of hospitalization in the elderly, and these patients are at high risk for subsequent hospitalization. Whether gender affects the risk of rehospitalization in patients who have CHF is less well understood. We studied a random sample of 1,700 adults who had been hospitalized with CHF (from July 1, 1999 to June 30, 2000) and identified all readmissions through June 30, 2001. We used proportional hazards regression to evaluate whether gender affects the risk of all-cause and CHF-specific rehospitalization, after adjusting for differences in demographic characteristics, health-related behaviors, co-morbid conditions, left ventricular systolic function status, and use of CHF therapies. Among 1,591 adults who had confirmed CHF, 752 were women (47.3%). Women were older than men (73 vs 71 years, p <0.001) and more likely to have preserved systolic function (55.3% vs 40.9%, p <0.001), hypertension (83.1% vs 75.2%, p <0.001), and prior renal insufficiency (46.8% vs 34.6%, p <0.001). No significant differences existed between women and men with respect to crude rates of any readmission (144.7 vs 134.6 per 100 person-years, p = 0.36) or CHF-specific readmission (39.9 vs 37.4 per 100 person-years, p = 0.65). After adjusting for potential confounders, there was no significant difference between women and men with respect to risk of any readmission (adjusted hazard ratio 0.88, 95% confidence interval 0.76 to 1.02) or readmission for CHF (adjusted hazard ratio 0.89, 95% confidence interval 0.71 to 1.11). Among a contemporary, diverse population of patients who had CHF, rates of readmission overall and for CHF remained high, but gender was not independently associated with a differential risk of readmission.

Entities:  

Mesh:

Year:  2004        PMID: 15518609     DOI: 10.1016/j.amjcard.2004.07.081

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

Review 1.  A systematic review of validated methods for identifying heart failure using administrative data.

Authors:  Jane S Saczynski; Susan E Andrade; Leslie R Harrold; Jennifer Tjia; Sarah L Cutrona; Katherine S Dodd; Robert J Goldberg; Jerry H Gurwitz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

Review 2.  Heart failure in women.

Authors:  J Julia Shin; Eman Hamad; Sandhya Murthy; Ileana L Piña
Journal:  Clin Cardiol       Date:  2012-03       Impact factor: 2.882

3.  Analysis of 10-year nationwide population-based data on sex differences in hospitalization for heart failure.

Authors:  Hung-Yu Yang; Wan-Chun Chiu; Jen-Hung Huang; Chien-Yeh Hsu; Yung-Kuo Lin; Yi-Jen Chen
Journal:  Heart Vessels       Date:  2012-10-23       Impact factor: 2.037

4.  Association of β-blocker exposure with outcomes in heart failure differs between African American and white patients.

Authors:  David E Lanfear; Tara N Hrobowski; Edward L Peterson; Karen E Wells; Tanmay V Swadia; John A Spertus; L Keoki Williams
Journal:  Circ Heart Fail       Date:  2012-01-19       Impact factor: 8.790

5.  Race and association of angiotensin converting enzyme/angiotensin receptor blocker exposure with outcome in heart failure.

Authors:  Mostafa El-Refai; Tara Hrobowski; Edward L Peterson; Karen Wells; John A Spertus; L Keoki Williams; David E Lanfear
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2015-09       Impact factor: 2.160

6.  Comparison of renal predictors for in-hospital and postdischarge mortality after hospitalized heart failure.

Authors:  Gurjit Singh; Edward L Peterson; Karen Wells; L Keoki Williams; David E Lanfear
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2012-04       Impact factor: 2.160

7.  Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis.

Authors:  Zeina A Habib; Leonidas Tzogias; Suzanne L Havstad; Karen Wells; George Divine; David E Lanfear; Jeffrey Tang; Richard Krajenta; Manel Pladevall; L Keoki Williams
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-06       Impact factor: 2.890

Review 8.  The heart failure epidemic.

Authors:  Véronique L Roger
Journal:  Int J Environ Res Public Health       Date:  2010-04-19       Impact factor: 3.390

9.  Comparing methods for identifying patients with heart failure using electronic data sources.

Authors:  Fadi Alqaisi; L Keoki Williams; Edward L Peterson; David E Lanfear
Journal:  BMC Health Serv Res       Date:  2009-12-18       Impact factor: 2.655

10.  Relationship of Loop Diuretic Dosing and Acute Changes in Renal Function during Hospitalization for Heart Failure.

Authors:  Mostafa El-Refai; Olesya Krivospitskaya; Edward L Peterson; Karen Wells; L Keoki Williams; David E Lanfear
Journal:  J Clin Exp Cardiolog       Date:  2011-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.